Aynaz Aynaz Ghorbani

Dr. Aynaz Aynaz Ghorbani


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2023 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
TSTUĞBA SEMERCİ SEVİMLİ
TUĞBA SEMERCİ SEVİMLİ
AGAynaz Aynaz Ghorbani
Aynaz Aynaz Ghorbani
FGFidan Gakhiyeva
Fidan Gakhiyeva
BCBahar Demir Cevizlidere
Bahar Demir Cevizlidere
MSmurat sevimli
murat sevimli

30 September 2023 in Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi
Verified
Journal Article
Open access
PDF file
TSTUĞBA SEMERCİ SEVİMLİ
TUĞBA SEMERCİ SEVİMLİ
AGAynaz Aynaz Ghorbani
Aynaz Aynaz Ghorbani
MSmurat sevimli
murat sevimli
Amaç: Akciğer kanseri, tüm dünyada hem kadın hem de erkeklerde en sık görülen kanser türüdür. Son yıllarda kanser konusunda elde edilen bilimsel gelişmelere rağmen, bu patoloji hala yüksek mortalite oranları ile ilk sıralarda yer almaktadır. Akciğer kanseri olgularının %85’ini küçük hücreli olmayan akciğer kanseri oluşturmaktadır. Bu hastalarda hastalığın seyri oldukça kötü ilerlemekte ve tanısı çoğunlukla ileri evrelerde konulduğundan, çoğu hastada uygulanan tedaviler başarılı olamamaktadır. Borik asit (BA) sahip olduğu kimyasal özellikler, düşük yan etki oranları ve anti-kanserojen etkilere sahip esansiyel bir mikro elementtir. Bu çalışma kapsamında anti-proliferatif ve anti-apoptotik etkileri bilinen BA’nın, küçük hücreli dışı akciğer kanseri hücreleri (A549) üzerindeki sitotoksik, anti-proliferatif ve apoptotik etkilerinin TGF-β sinyal yolağı üzerinden araştırılması amaçlanmıştır. Yöntem: Çalışmada insan küçük hücreli dışı akciğer kanseri hücreleri (A549) kullanıldı. BA’nın sitotoksik analizi MTT analizi ile yapıldı. BA’nın apoptotik etkisi Annexin V/PI ve immünfloresan analizlerle belirlendi. TGF-β, SMAD2/3/4 genlerinin ekspresyon düzeyleri moleküler düzeyde kantitatif gerçek zamanlı polimeraz zincir reaksiyonu (RT-qPCR) ile analiz edildi. Her bir reaksiyon üç kez tekrarlandı. Bulgular: MTT analizi sonucu 50 mM BA’nın A549 hücrelerinde proliferasyonu azalttığı gözlendi (p<0.01). 50 mM BA uygulaması ile 48. saatte apoptotik hücre oranı %9.7’ye, erken apoptoz evresindeki hücre oranı ise %10.1’e yükseldi. İmmünfloresan analizinde de A549 hücrelerinde Kaspaz-3 işaretlenme düzeyininin kontrol grubuna göre yüksek miktarda olduğu gözlendi. BA uygulanan A549 hücrelerinde SMAD3 ve SMAD4 genlerinin ifadesinde anlamlı bir değişme gözlenmedi. TGF-β geninin ifadesinde azalma gözlenirken (p<0.05), SMAD2 gen ifadesinde artış gözlendi (p<0.01). Sonuç: Sonuçlar BA’nın; anti-proliferatif ve anti-apoptotik aktiviteye sahip yeni bir tedavi edici ajan olabileceğini göstermektedir. Ancak bu etkilere aracılık eden yolakların aydınlatılması için ileri düzeyde çalışmalara ihtiyaç bulunmaktadır.

4 July 2024 in Biological Trace Element Research
Verified
Journal Article
Open access
PDF file
TSTUĞBA SEMERCİ SEVİMLİ
TUĞBA SEMERCİ SEVİMLİ
AGAynaz Aynaz Ghorbani
Aynaz Aynaz Ghorbani
FGFidan Gakhiyeva
Fidan Gakhiyeva
Aliakbar EbrahimiAliakbar Ebrahimi
Aliakbar Ebrahimi
HGHamed Ghorbanpoor
Hamed Ghorbanpoor
ETEmre Tufekcioglu
Emre Tufekcioglu
Coregulation of microRNAs (miRNAs) and cancer stem cells (CSCs) is very important in carcinogenesis. miR-127-5p is known to be downregulated in breast cancer. In this study, we aimed to investigate how boric acid (BA), known for its previously unstudied anti-cancer properties, would affect the expression of miR127-5p and genes responsible for breast cancer stem cells (BC-SCs) metastasis. BC-SCs were isolated from human breast cancer cells (MCF-7) by immunomagnetic cell separation and characterized with flow cytometry and sphere formation. The viability of BC-SCs and the determination of its IC50 value in response to boric acid (BA) were assessed via the MTT assay. Boric acid exhibited dose- and time-dependent inhibition of cell viability in cells. The IC50 doses of boric acid in MCF-7 cells and BC-SCs were 45.69 mM and 41.27 mM, respectively. The impact of BA on the expression of metastatic genes and miR127-5p was elucidated through RT-qPCR analysis. While the expression of the COL1A1 (p < 0.05) and VIM (p < 0.01) was downregulated, the expression of the miR-127-5p, ZEB1 (p < 0.01), CDH1 (p < 0.05), ITGB1 (p < 0.05), ITGA5 (p < 0.05), LAMA5 (p < 0.01), and SNAIL (p < 0.05), was up-regulated in dose-treated BC-SCs (p < 0.001) to the RT-qPCR results. Our findings suggest that boric acid could induce miR-127-5p expression. However, it cannot be said that it improves the metastasis properties of breast cancer stem cells. Graphical Abstract

17 February 2024 in Biological Trace Element Research
Verified
Journal Article
Open access
PDF file
TSTUĞBA SEMERCİ SEVİMLİ
TUĞBA SEMERCİ SEVİMLİ
AGAynaz Aynaz Ghorbani
Aynaz Aynaz Ghorbani
BCBahar Demir Cevizlidere
Bahar Demir Cevizlidere
BABurcugül Altuğ
Burcugül Altuğ
MSmurat sevimli
murat sevimli
DNA double-strand break (DSB) repair genes interact with tumor stemness- and resistance-associated processes in cancer stem cells (CSCs). Therefore, targeting DNA DSB genes in cancer treatment is important for the CSC phenotype. Although the anti-cancer effect of boric acid (BA) has been studied, its effect on DNA DSB is unclear. Moreover, no studies investigate BA’s effects on DNA DSB of lung cancer stem cells (LC-SCs). To fill the gap, we aimed to assess the effects of BA on A549 cancer stem cells. CSCs were isolated from human non-small cell lung cancer cells (A549) and characterized by flow cytometry. Different concentrations of BA (at doses ranging from 1 to 100 mM) were applied to cancer stem cells. Cytotoxic activities were determined using the cell viability assay (MTT assay) at 24 and 48 h. Expression levels of DNA DSB genes that BRCA1, BRCA2, RAD51, KU70/80, ATM, and XRCC4 were evaluated by RT-qPCR. Additionally, immunofluorescence staining analysis was exploited for caspase-3 and E-cadherin. ATM expression increased significantly (p < 0.001). No significant change was observed in the expression of other genes. Moreover, BA up-regulated caspase-3 and E-cadherin expression. Consequently, we can say that BA affects DNA DSB and the apoptotic abilities of LC-SCs. Graphical Abstract

11 December 2025 in The Veterinary Journal
Verified
Journal Article
Closed access
DHDurmus Hatipoglu
Durmus Hatipoglu
MAMEHMET BURAK ATEŞ
MEHMET BURAK ATEŞ
ASAyla Eker Sariboyaci
Ayla Eker Sariboyaci
OUOnur Uysal
Onur Uysal
MSMerve Nur Soykan
Merve Nur Soykan
FAFatih Aladag
Fatih Aladag

2 October 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
AGAynaz Aynaz Ghorbani
Aynaz Aynaz Ghorbani
OUOnur Uysal
Onur Uysal
DKDilay Karacaoğlu
Dilay Karacaoğlu
Background: Gemcitabine is used in the treatment of human non-small cell lung cancer (hNSCLC), yet acquired resistance can limit therapeutic responses. Small extracellular vesicles (sEVs) and microRNAs (miRNAs) have been implicated in chemoresistance-associated intercellular signaling. We profiled the miR-221/222 cluster and resistance-associated genes in cancer stem-like cells (CSLCs) and CSLC-derived sEV preparations from gemcitabine-sensitive and -resistant A549 models. Methods: Gemcitabine-resistant A549 cells and matched cancer stem-like cell (CSLC) and gemcitabine-resistant cancer stem-like cell (Gr-CSLC) populations were generated and characterized by flow cytometry, qRT-PCR, and immunofluorescence. sEV preparations derived from CSLC and Gr-CSLC spheroids were characterized for total protein content, EV-associated tetraspanins, and vesicular morphology. PKH26-associated fluorescence following exposure of A549 cells to labeled sEV preparations was also evaluated. The relative levels of sEV-associated miR-221/222 family members and the resistance-associated genes MDR1, ABCG2, and BCL2 were assessed by qRT-PCR. Results: Gr-CSLCs exhibited enhanced spheroid formation and increased MDR1 expression. Gr-CSLC-derived sEV preparations showed higher total protein content than CSLC-derived preparations. Bead-based flow cytometry demonstrated EV-associated CD9 and CD81 expression, while cryo-TEM revealed small, membrane-bound vesicular structures. PKH26-associated intracellular fluorescence was observed in A549 cells following exposure to labeled sEV preparations. Gr-CSLC-derived sEVs showed higher relative levels of miR-221-3p, miR-222-3p, and miR-222-5p than CSLC-derived sEVs, whereas miR-221-5p showed no significant difference. MDR1 and BCL2 also showed higher relative expression in Gr-CSLC-derived sEVs, whereas ABCG2 showed no significant difference. Conclusions: sEV preparations derived from gemcitabine-resistant Gr-CSLCs exhibited distinct miR-221/222 and resistance-associated RNA profiles compared with those derived from gemcitabine-sensitive CSLCs in this in vitro A549 NSCLC model. These molecular differences should be interpreted as associations with the resistant phenotype rather than evidence of functional transfer of chemoresistance. Further functional studies and validation in additional NSCLC and patient-derived models are required to establish their biological, therapeutic, or biomarker relevance.